Journal profile · Dermatology
Pigment Cell & Melanoma Research
ISSN 1755-1471 · eISSN 1755-148X · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · Founded 2008
Pigment Cell & Melanoma Research: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.45; hybrid open access; APC about USD 5,000; median 135 days to acceptance (83 articles, last 24 months); community-reported acceptance: fairly hard; 82 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pigment Cell & Melanoma Research is published by Wiley-Blackwell Publishing Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are melanin and skin pigmentation, Melanoma and MAPK Pathways and Cutaneous Melanoma Detection and Management, together about 47.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Pigment Cell & Melanoma Research publishes manuscripts on all aspects of normal and transformed pigment cells including development, cell and molecular biology, genetics, diseases of pigment cells including melanoma, and therapeutic interventions. Papers that provide insights into the causes and progression of melanoma including the process of metastasis and invasion, proliferation, senescence, apoptosis or gene regulation are especially welcome, as are papers that use the melanocyte system to answer questions of general biological relevance. Papers that are purely descriptive or make only minor advances to our knowledge of pigment cells or melanoma are less suited for this journal.
From the journal's Aims & Scope
Research area (LetPub): Dermatology
Editor-in-chief I. Caroline Le PoolePublisher website
Editorial board by country: none in mainland China; most named United States 2, Netherlands 2, Japan 1, Australia 1 (6 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- melanin and skin pigmentationBiochemistry, Genetics and Molecular Biology27%
- Melanoma and MAPK PathwaysBiochemistry, Genetics and Molecular Biology11.5%
- Cutaneous Melanoma Detection and ManagementMedicine9.2%
- Skin Protection and AgingMedicine8.5%
- Biochemical Analysis and Sensing TechniquesNursing6.2%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.6%
- RNA regulation and diseaseBiochemistry, Genetics and Molecular Biology4.4%
- Cell Adhesion Molecules ResearchMedicine2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Dermatology | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 2 |
| Minor | Cell Biology | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.45LetPub ·
- Impact factor (publisher) 2025
- 3.5Publisher website ·
- CiteScore 2026-06
- 5.1LetPub ·
- CiteScore (publisher) 2025
- 5.1Publisher website ·
- SJR 2026-06
- 1.19LetPub ·
- SNIP 2026-06
- 1.2LetPub ·
- h-index
- 92LetPub ·
- h-index
- 116OpenAlex ·
- i10-index
- 1,004OpenAlex ·
- 2-year mean citedness
- 3.2OpenAlex ·
- Self-citation rate
- 5.7%LetPub ·
- Share of gold OA articles
- 41.07%LetPub ·
Volume
- Articles per year
- 64LetPub ·
- Articles per year (publisher) 2025
- 66Publisher website ·
- Downloads per year (publisher) 2025
- 431,151Publisher website ·
Articles by year OpenAlex count · 2,083 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 53 | 35 | 8 |
| 2025 | 82 | 51 | 191 |
| 2024 | 74 | 46 | 470 |
| 2023 | 73 | 52 | 422 |
| 2022 | 60 | 33 | 720 |
| 2021 | 77 | 33 | 1,383 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
135 daysMedian, submission to acceptance · P25–P75 73 days – 187 days
- Acceptance to online
- median 18 days (83 articles)
- Submission to online
- median 155 days
- Sample
- 83 articles with submission and acceptance dates (143 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Acceptance rate (publisher) 2025
- 24%Publisher website ·
- Submission to first decision 2025
- 11 daysPublisher website ·
- Submission to acceptance 2025
- 145 daysPublisher website ·
- Acceptance to publication 2025
- 16 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,000 / EUR 4,150 / GBP 3,300 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
Article types accepted14
- commentariesCommentaries: This category is meant to serve as a forum to voice opinions on published papers or on issues relevant to the pigment and melanoma communities.Length not stated
- commentaryOriginal Research Articles: Manuscripts for this category are expected to have novel and in-depth data that contribute toward a major and significant advance in…Length not stated
- editorialOriginal Research Articles: Manuscripts for this category are expected to have novel and in-depth data that contribute toward a major and significant advance in…Length not stated
- letterOriginal Research Articles: Manuscripts for this category are expected to have novel and in-depth data that contribute toward a major and significant advance in…Length not stated
- letters to the editorOriginal Research Articles: Manuscripts for this category are expected to have novel and in-depth data that contribute toward a major and significant advance in…Length not stated
- method papersMethod Papers: PCMR now accepts manuscripts describing protocols and/or methods that are specifically relevant to pigment cell and melanoma research.Length not stated
- opinionOriginal Research Articles: Manuscripts for this category are expected to have novel and in-depth data that contribute toward a major and significant advance in…Length not stated
- original research articleOriginal Research Articles: Manuscripts for this category are expected to have novel and in-depth data that contribute toward a major and significant advance in…Length not stated
- original research articlesOriginal Research Articles: Manuscripts for this category are expected to have novel and in-depth data that contribute toward a major and significant advance in…Length not stated
- research paperOriginal Research Articles: Manuscripts for this category are expected to have novel and in-depth data that contribute toward a major and significant advance in…Length not stated
- resourcesResources: Researchers who developed unique reagents (antibodies, cell lines, animal models, etc.), databases, and innovative technology approaches relevant to …Length not stated
- review articlesReview Articles: These articles are expected to provide an in-depth discussion of the current state of a field through an exhaustive literature survey; an Abstr…Length not stated
- short articles (communications)Short Articles (Communications): Manuscripts reporting data from research that has progressed to a point where important preliminary observations should be diss…Length not stated
- systematic reviewsSystematic Reviews: Covers all published data on a defined topic by performing a systematic search on specific research question(s), according to accepted syste…Length not stated
Policy excerpts from the journal's websiteAuthorship, Code availability, Data availability, Publication ethics, Peer review, Preprints
- Authorship 7. Author Contributions (CRediT)
This journal requires details of all authors’ contributions to the work by filling out CRediT (Contribution Roles Taxonomy) information during revision. This information provided will be used to automatically generate an author contribution statement that will be published with the final article. You can learn more about CRediT and read an explanation of contribution roles on Wiley's CRediT inform…
Source ↗Publisher website ·- Code availability
Participates in Wiley Refer & Transfer program Model summary
This journal participates in Wiley’s Refer & Transfer program.
Source ↗Publisher website ·- Data availability
Data sharing encouraged Model summary
The journal encourages authors to share the data and other resources supporting the results in the paper by depositing them in an appropriate public repository.
Source ↗Publisher website ·- Publication ethics 5. Editorial Policies and Ethical Considerations
Peer Review and AcceptanceThe acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Wiley's policy on the conf…
Source ↗Publisher website ·- Peer review
Single-blind peer review Model summary
Except where otherwise stated, manuscripts are single-blind peer reviewed.
Source ↗Publisher website ·- Preprints
Preprint policy: considers preprints Model summary
This journal will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, etc.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2008
- ISSN
- 1755-1471
- Electronic ISSN
- 1755-148X
- Society / sponsor
- International Federation of Pigment Cell Societies
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pigment Cell & Melanoma Research
What CAS zone is Pigment Cell & Melanoma Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pigment Cell & Melanoma Research is in Zone 3 of Medicine, and in Zone 3 of the minor category Cell Biology / Dermatology / Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pigment Cell & Melanoma Research?
The latest impact factor listed by LetPub is 3.45; CiteScore 5.1, h-index 116.
How long does peer review take at Pigment Cell & Melanoma Research?
Based on the dates recorded on 83 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 135 days (interquartile range 73–187 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly hard”; the journal's website gives an acceptance rate of 24% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pigment Cell & Melanoma Research?
According to the journal's author guidelines: Reference style: Author–date; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pigment Cell & Melanoma Research based?
Of the 6 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (2), Netherlands (2) and Japan (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Pigment Cell & Melanoma Research?
According to LetPub and DOAJ records, Pigment Cell & Melanoma Research is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Pigment Cell & Melanoma Research open access, and what is the APC?
Pigment Cell & Melanoma Research is a hybrid journal. For open-access publication: APC about USD 5,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .